In an assertive regulatory move, the Food Safety and Standards Authority of India has issued formal show-cause notices to fast-moving consumer goods giants Hindustan Unilever Limited and Nestlé India. The statutory action targets unsubstantiated therapeutic assertions, unauthorized product categories, and deceptive packaging declarations on popular commercial formulations. For medical practitioners, clinical nutritionists, and primary care physicians, these FSSAI misleading claims highlight a critical gap between front-of-pack commercial promises and the physiological realities of dietary management. Consequently, healthcare providers must carefully examine the formulation specifics of commercial health drinks routinely consumed by their patient cohorts.

Regulatory Framework and Enforcement Priorities

The apex food regulator enforces strict standards through the Food Safety and Standards (Advertising and Claims) Regulations, 2018, and the Food Safety and Standards (Labelling and Display) Regulations, 2020. These frameworks explicitly mandate that all claims must remain truthful, unambiguous, and scientifically validated through robust clinical evidence. Furthermore, regulations strictly forbid brand narratives that exaggerate clinical efficacy or suggest guaranteed physiological outcomes without statutory authorization.

In this recent enforcement drive, the regulatory body scrutinized both physical packaging labels and e-commerce marketing banners. The authority observed that digital commerce portals frequently display expanded marketing descriptions that exceed approved label claims. Therefore, the regulator requested licensing bodies and digital marketplaces to initiate swift administrative action against non-compliant product listings. This coordinated scrutiny signals a comprehensive regulatory transition toward total transparency across physical distribution channels and digital storefronts alike. Medical specialists welcome this rigor, as patient choices often stem from commercially amplified wellness promises rather than sound clinical guidance.

Decoding the FSSAI Misleading Claims Against HUL

The regulatory authority issued a comprehensive notice to Hindustan Unilever regarding its formulation, Horlicks Women’s Plus Chocolate Nutrition Drink. Specifically, the packaging boldly promoted statements such as “Nutrition for Strong Bones” and “Clinically Proven to Help Improve Bone Strength in 6 Months.” Additionally, the label prominently claimed that the formulation directly “Improves Bone Health.” The regulator determined that these promotional assertions breached applicable statutory standards governing health and nutritional claims.

Moreover, the manufacturer displayed the phrase “healthy Muscles” on the exterior carton. The statutory authorities flagged this terminology because it violates clear regulations governing the permissive use of the descriptor “healthy.” Food business operators cannot employ absolute health assertions without satisfying rigorous nutrient composition benchmarks. Furthermore, the company highlighted a claim of supplying “100 per cent RDA of Calcium, Vitamin D & K2.” However, regulatory verification revealed that this declaration failed to satisfy mandatory food safety benchmarks. Such discrepancies raise meaningful concerns for orthopedic specialists and endocrinologists treating osteopenia and postmenopausal bone mineral density decline.

Hidden Carbohydrates and the Sugar Paradox

Perhaps the most clinically significant finding regarding Horlicks Women’s Plus involves its front-of-pack “No Added Sugar” marketing banner. The regulatory authority deemed this statement misleading due to the substantial presence of maltodextrin within the product matrix. Although manufacturers technically avoid adding refined sucrose, maltodextrin functions as a rapidly digestible polysaccharide derived from processed starches.

Importantly, maltodextrin possesses a high glycemic index, often ranging between 85 and 105, which exceeds that of standard table sugar. Consequently, its consumption prompts rapid postprandial glucose surges and triggers abrupt insulin secretion. Diabetic, insulin-resistant, and metabolic syndrome patients frequently consume formulations advertising “No Added Sugar” under the assumption that they are safe. However, hydrolysed starches undermine glycemic control and worsen metabolic parameters. Physicians must therefore educate patients that the absence of sucrose does not imply carbohydrate restriction. Clinicians must advise patients to read the entire ingredient list rather than trusting prominent front-of-pack marketing claims.

Maternal Marketing and Questionable Fetal Claims

In a parallel proceeding, the regulator directed a show-cause notice to HUL regarding Horlicks Mother’s Plus Kesar. The commercial label prominently featured the phrase “Healthy Birth Weight,” while corresponding broadcast advertisements claimed “For baby’s healthy birth weight.” The regulatory body classified these phrases as potentially deceptive representations that breach the 2018 Advertising and Claims Regulations.

Additionally, the manufacturer included marketing text directly within digital retail listings, describing the drink as “For Pregnancy and Lactation with Protein for Birth Weight and DHA for Brain Development – No Added Sugar.” From an obstetrical perspective, fetal birth weight represents a multifactorial clinical outcome governed by maternal genetics, placental perfusion, gestational age, and total balanced dietary intake. Attributing optimal neonatal birth weight to a single commercial malt powder oversimplifies antenatal physiology. Furthermore, misleading advertising can cause vulnerable pregnant individuals to rely on commercial powders rather than consuming micronutrient-dense whole foods and prescribed prenatal supplements.

Unapproved Medical Foods: The Nestlé Resource Renal Scrutiny

The regulatory authority also tackled clinical nutrition compliance by issuing a notice to Nestlé India concerning its Resource Renal Vanilla Flavour Powder. This formulation targets individuals requiring dietary management for conservatively treated chronic kidney disease. Under the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022, foods for special medical purposes require mandatory prior regulatory approval.

However, the food safety authority determined that Nestlé India marketed this specialized medical food without securing the essential prior clearance. Chronic kidney disease demands precise electrolyte restriction, carefully tailored protein intake, and controlled phosphorus-to-protein ratios. Unapproved clinical nutrition products present substantial risks of electrolyte derangements or accelerated glomerular filtration decline. In addition, the regulator cited the omission of mandatory vegetarian or non-vegetarian classification logos on the packaging. Hence, nephrologists must verify regulatory compliance before recommending specialized commercial formulas to patients with renal impairment.

Packaging Discrepancies and Necessary Clinical Vigilance

Beyond specialized nutritional supplements, the regulatory watchdog investigated Nestlé India alongside co-manufacturers Schreiber Dynamix Dairies and Lotus Dairy Products for ready-to-drink coffee beverages. Products including Nescafé Intense Café, Choco Mocha, and Chilled Latte exhibited contradictory classification labels. Specifically, the front panel declared the beverage as “Flavoured Milk,” whereas the back panel described the contents as “Proprietary Food – Dairy Based Drink.”

Similarly, corresponding digital marketplace listings promoted the beverage with claims such as “crafted with the goodness of flavoured double toned milk,” contradicting statutory product categories. These pervasive discrepancies demonstrate why healthcare practitioners must maintain a high index of suspicion regarding commercial nutritional marketing. Physicians should actively instruct patients to scrutinize the complete nutritional facts panel and mandatory ingredient schedules. By promoting nutritional literacy, healthcare professionals safeguard vulnerable cohorts from misleading marketing practices and ensure evidence-based dietary choices.

Frequently Asked Questions

Q1: Why did the food regulator flag the "No Added Sugar" claim on Horlicks Women's Plus?

The regulatory authority declared the claim misleading because the formulation contains maltodextrin. Although manufacturers do not add refined sucrose, maltodextrin represents a rapidly absorbed carbohydrate with a very high glycemic index. Consequently, the powder can rapidly spike blood glucose levels, creating significant clinical risks for diabetic or insulin-resistant individuals who consume the product believing it lacks glycemic carbohydrates.

Q2: What regulatory violations were identified regarding Nestlé Resource Renal powder?

Nestlé India marketed Resource Renal Vanilla Flavour Powder without obtaining mandatory prior approval under the FSS Regulations, 2022. Because the formulation targets individuals undergoing conservative management for chronic kidney disease, it qualifies as a Food for Special Medical Purpose. Such products require strict pre-market safety evaluation. Furthermore, the product lacked the mandatory vegetarian or non-vegetarian indicator logo.

Q3: How do unsubstantiated maternal nutrition claims impact prenatal clinical care?

Claims suggesting that a commercial drink ensures a healthy birth weight mislead expectant mothers by oversimplifying fetal growth. Fetal development depends on maternal genetics, placental health, and balanced micronutrient intake. When patients believe a processed powdered drink guarantees normal birth weight, they may neglect balanced whole foods or essential clinical supplements, compromising comprehensive maternal and fetal care.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.

References

1. FSSAI issues notices to Nestle India, Hindustan Unilever for misleading claims - ETHealthworld


2. Food Safety and Standards Authority of India. Food Safety and Standards (Advertising and Claims) Regulations, 2018. New Delhi: Ministry of Health and Family Welfare, Government of India; 2018.


3. Food Safety and Standards Authority of India. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022. New Delhi: Ministry of Health and Family Welfare; 2022.


4. Hofman DL, van Buul VJ, Brouns FJ. Nutrition, Metabolism and Health Aspects of Maltodextrin: A Review. Crit Rev Food Sci Nutr. 2016;56(12):2091-2100.